Public map story

Eve Hewson · Vivid Mosaic

The global conversation: News pulse 2026-08-26 · Reuters: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. A perspective from Berlin.

party · Berlin, DE · 0 likes · 2 replies